Frontiers in Genome Editing
Clinical translation of CRISPR-Cas9 therapeutics in cancer and inherited genetic disorders
ReviewInterventions
Abstract
CRISPR-Cas9, adapted from the bacterial Type II CRISPR adaptive immune system, functions as a programmable RNA-guided endonuclease that employs a single-guide RNA to direct Cas9 to specific genomic loci.
The paper
Vellore Institute of Technology University
Frontiers in Genome Editing, 10 Sep 2026, CC BY